Drug · DIN 02230700
HYPERRAB S/D
ALSO KNOWN AS RABIES IMMUNE GLOBULIN HUMAN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 8, 2022; first marketed October 9, 1997.
- Drug Identification Number (DIN)
- 02230700
- Company (DIN owner)
- Grifols Therapeutics LlcClayton, North Carolina, United States
- Schedule
- Schedule d
- Dosage form
- Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Rabies immunoglobulin J06BB05
- Class
- Human
- Record last updated
- August 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RABIES IMMUNOGLOBULIN (HUMAN) | 150 UNIT | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 30, 2012: NOC 12983New Drug Submission (NDS) · Manufacturer name chage
- June 8, 2005: NOC 7077New Drug Submission (NDS) · Manufacturer and product name change
- February 12, 1997: NOC 4042New Drug Submission (NDS)